# Li Jing

> Li Jing is a seed investor at Qingsong Capital backing Medical and Biotechnology. See 3 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Qingsong Capital](https://shizune.co/investors/profile/qingsong-capital)
- Total investments: 3
- Last investment: Jun 2024
- Lead investor: 33%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/jing-li-a59289129

Li Jing is a seed investor at Qingsong Capital focused on Medical and Biotechnology. Li Jing is the project manager of Qingsong Capital.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 2 | 67% |
| Biotechnology | 2 | 67% |
| Biopharma | 1 | 33% |
| Health Diagnostics | 1 | 33% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 1 | 33% |
| Series A | 1 | 33% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Genewise Bio | Genewise Bio is a biotechnology company that specializes in the technological iteration of POCT in molecular diagnostics. | $14.1M | Series A | Jun 04, 2024 |  |
| Ouli Biomedical | Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration. |  | Seed | Mar 09, 2023 |  |
| Ouli Biomedical | Ouli Biomedical is a pharmaceutical company. They offer nucleic acid drug discovery, laboratory research and development, process and analysis development, CMC services, API production, and drug registration. |  | Seed | Mar 09, 2023 |  |

3 of 3 investments shown.

## Co-investors
- [Addor Capital](https://shizune.co/investors/profile/addor-capital) — VC Fund, 2 deals together
- [Matrix Partners China](https://shizune.co/investors/profile/matrix-partners-china) — VC Fund, 2 deals together
- [Aeonmed Medical Treatment](https://shizune.co/investors/profile/aeonmed-medical-treatment) — VC Fund, 1 deal together
- [Pine Capital](https://shizune.co/investors/profile/pine-capital) — VC Fund, 1 deal together
- [Pinnacles Medical](https://shizune.co/investors/profile/pinnacles-medical) — VC Fund, 1 deal together
- [Qingsong Capital](https://shizune.co/investors/profile/qingsong-capital) — VC Fund, 1 deal together

## About Qingsong Capital

VC Fund · Beijing, China

Qingsong Capital is an entrepreneurial private equity investment institution focusing on the investments in the field of biotechnology and medical health.

2 contacts available at Qingsong Capital.

| Name | Title | Profile |
| --- | --- | --- |
| Li Jing | Executive Director | https://shizune.co/investors/profile/li-jing-fce9 |
| Zhang Song | Founding Partner | https://shizune.co/investors/profile/zhang-song |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Li Jing invest in?

Li Jing invests primarily in Medical, Biotechnology and Biopharma startups, most often at Seed and Series A stage. Most of the 3 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Li Jing last invest?

The most recent investment recorded for Li Jing closed in Jun 2024. Shizune tracks 3 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co